跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pateamine A
首页
药物
Pateamine A
Pateamine A
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Anticancer agents and use
US 7737134 B2
申请人: TEXAS A & M UNIV SYS
优先权: 2006
US
4 件公开
EIF4A INHIBITORS AND USES THEREOF
EP 4554571 A4
申请人: UNIV CALIFORNIA
优先权: 2022
EP
WO
2 件公开
Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia
US 10407444 B2
申请人: TEXAS A & M UNIV SYS
优先权: 2016
US
2 件公开
Potent, simplified derivatives of pateamine A
US 7230021 B2
申请人: TEXAS A & M UNIV SYS
优先权: 2003
US
Use of Pateamine A for the treatment of age-related muscle wasting
US 9358249 B2
申请人: HUANG JING
优先权: 2008
US
Beta-amino pateamine a derivatives and methods for treating chronic lymphocytic leukemia
US 10889596 B2
申请人: TEXAS A & M UNIV SYS
优先权: 2017
US
METHODS FOR TREATING PANCREATIC CANCER WITH A COMBINATION OF DES-METHYL PATEAMINE A AND A CLASS 1 HDAC INHIBITOR
WO 2024254195 A1
申请人: UNIV BAYLOR
优先权: 2023
WO
药物
反馈